Skip to main content
Clinical Trials/NCT02121847
NCT02121847
Completed
Phase 4

Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy

Allergan0 sites40 target enrollmentApril 3, 2014

Overview

Phase
Phase 4
Intervention
carboxymethylcellulose-based lubricant eye drops
Conditions
Dry Eye Syndromes
Sponsor
Allergan
Enrollment
40
Primary Endpoint
Change From Baseline in Total Corneal Staining Score With Lissamine Green in the Worse Eye
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

This study will evaluate the safety and efficacy of cyclosporine 0.05% ophthalmic emulsion (Restasis®) in patients with dry eye disease.

Registry
clinicaltrials.gov
Start Date
April 3, 2014
End Date
September 23, 2014
Last Updated
7 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Allergan
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • History of dry eye in both eyes
  • Willing to use eye drops for dry eye symptoms

Exclusion Criteria

  • Anticipate wearing contact lenses during the study
  • Laser-assisted in situ keratomileusis (LASIK) surgery within the past 12 months
  • Any ocular and/or lid surgeries within the past 6 months
  • Cataract surgery in either eye
  • Current or anticipated use of temporary punctal plugs during the study

Arms & Interventions

cyclosporine 0.05% ophthalmic emulsion

Cyclosporine 0.05% ophthalmic emulsion (Restasis®) eye drops administered twice daily and carboxymethylcellulose-based lubricant eye drops (Refresh OPTIVE® Advanced) administered as needed for 6 months.

Intervention: carboxymethylcellulose-based lubricant eye drops

cyclosporine 0.05% ophthalmic emulsion

Cyclosporine 0.05% ophthalmic emulsion (Restasis®) eye drops administered twice daily and carboxymethylcellulose-based lubricant eye drops (Refresh OPTIVE® Advanced) administered as needed for 6 months.

Intervention: cyclosporine 0.05% ophthalmic emulsion

Outcomes

Primary Outcomes

Change From Baseline in Total Corneal Staining Score With Lissamine Green in the Worse Eye

Time Frame: Baseline, Month 6

Total corneal staining with lissamine green is measured in the worse eye utilizing the Ora CalibraTM Corneal Lissamine Staining Scale (0 to 4 scale where 0=no staining and 4= severe staining). The sum of the total includes 3 regions of the cornea, resulting in a maximum possible score of 12 (severe staining score of 4 in all three regions). A negative change from baseline represents a decrease in staining (improvement). A positive change from baseline represents an increase in staining (worsening).

Change From Baseline in Driving at Night on the OSDI

Time Frame: Baseline, Month 6

The OSDI consists of 12 questions measuring the presence of ocular symptoms. The driving at night question is assessed using a 5-point scale (0=none of the time; 4=all of the time). The driving at night score is converted to a 0-100 score where 0 is best and 100 is worst. Higher OSDI reading scores are associated with greater severity. A negative number change from baseline indicates improvement and a positive number change from baseline indicates worsening.

Change From Baseline in Total Corneal Staining Score With Fluorescein in the Worse Eye

Time Frame: Baseline, Month 6

Total corneal staining with fluorescein is measured in the worse eye utilizing the Ora CalibraTM Corneal Flourescein Staining Scale (0 to 4 scale where 0=no staining and 4= severe staining). The sum of the total includes 3 regions of the cornea, resulting in a maximum possible score of 12 (severe staining score of 4 in all three regions). A negative change from baseline represents a decrease in staining (improvement). A positive change from baseline represents an increase in staining (worsening).

Change From Baseline in Total Conjunctival Staining Score With Lissamine Green in the Worse Eye

Time Frame: Baseline, Month 6

Total conjunctival staining with lissamine is measured in the worse eye utilizing the Ora CalibraTM Conjunctiva Lissamine Staining Scale (0 to 4 scale where 0=no staining and 4= severe staining). The sum of the total includes 2 regions of the conjunctiva, resulting in a maximum possible score of 8 (severe staining score of 4 in both regions). A negative change from baseline represents a decrease in staining (improvement). A positive change from baseline represents an increase in staining (worsening).

Change From Baseline in Total Conjunctival Staining Score With Fluorescein in the Worse Eye

Time Frame: Baseline, Month 6

Total conjunctival staining with fluorescein is measured in the worse eye utilizing the Ora CalibraTM Conjunctiva Flourescein Staining Scale (0 to 4 scale where 0=no staining and 4= severe staining). The sum of the total includes 2 regions of the conjunctiva, resulting in a maximum possible score of 8 (severe staining score of 4 in both regions). A negative change from baseline represents a decrease in staining (improvement). A positive change from baseline represents an increase in staining (worsening).

Change From Baseline in Working With a Computer or Bank Machine on the OSDI

Time Frame: Baseline, Month 6

The OSDI consists of 12 questions measuring the presence of ocular symptoms. The working with a computer or bank machine question is assessed using a 5-point scale (0=none of the time; 4=all of the time). The working with a computer or bank machine score is converted to a 0-100 score where 0 is best and 100 is worst. Higher OSDI reading scores are associated with greater severity. A negative number change from baseline indicates improvement and a positive number change from baseline indicates worsening.

Change From Baseline in Reading Rate

Time Frame: Baseline, Month 6

Reading speed is assessed as the number of words read correctly in 2 minutes.

Change From Baseline in Words Read Incorrectly

Time Frame: Baseline, Month 6

The numbers of words read incorrectly are counted in 2 minutes. A positive change from baseline indicates a worsening, and a negative change from baseline indicates an improvement.

Change From Baseline in Reading on the Ocular Surface Disease Index (OSDI)

Time Frame: Baseline, Month 6

The OSDI consists of 12 questions measuring the presence of ocular symptoms. The reading question is assessed using a 5-point scale (0=none of the time; 4=all of the time). The reading score is converted to a 0-100 score where 0 is best and 100 is worst. Higher OSDI reading scores are associated with greater severity. A negative number change from baseline indicates improvement and a positive number change from baseline indicates worsening.

Change From Baseline in Watching TV on the OSDI

Time Frame: Baseline, Month 6

The OSDI consists of 12 questions measuring the presence of ocular symptoms. The watching TV question is assessed using a 5-point scale (0=none of the time; 4=all of the time). The watching TV score is converted to a 0-100 score where 0 is best and 100 is worst. Higher OSDI reading scores are associated with greater severity. A negative number change from baseline indicates improvement and a positive number change from baseline indicates worsening.

Change From Baseline in Font Size

Time Frame: Baseline, Month 6

The minimum font (letter) size read correctly is assessed. Smaller font size indicates better ability. A negative change from baseline indicates an improvement and a positive change from baseline indicates a worsening.

Secondary Outcomes

  • Change From Baseline in Ocular Discomfort on a 4-point Scale(Baseline, Month 6)
  • Change From Baseline in Tear Film Break-up Time in the Worse Eye(Baseline, Month 6)
  • Change From Baseline in OSDI(Baseline, Month 6)
  • Change From Baseline in the Interblink Interval in the Worse Eye(Baseline, Month 6)
  • Change From Baseline in Conjunctival Redness in the Worse Eye(Baseline, Month 6)

Similar Trials